EpiEndo Raises Eur 2 Million in Equity
We are pleased to announce that we have successfully closed our 4th seed round of 2 million Euros. The round was led by a ABC Venture ehf,
The funds will be used to take our candidate drug through GLP tox and API development and get Phase I ready.
131 views0 comments